Firmenbeschreibung
Die Evotec SE zählt zu den weltweit führenden Wirkstoffforschungs- und -entwicklungsunternehmen. Die Firma ist auf neurale Erkrankungen, Schmerz, Stoffwechsel- und Entzündungskrankheiten sowie Onkologie spezialisiert. Das Kerngeschäft bildet die Wirkstoffforschung, die in Kooperation mit Partnerunternehmen aus der Pharma- und Biotechnologieindustrie realisiert wird. Unternehmen, die ihre Wirkstoffentwicklung auslagern wollen, werden hochwertige Lösungen und Dienstleistungen in diesem Bereich angeboten. Evotec übernimmt dabei alle Aktivitäten bis hin zur klinischen Entwicklung. Das Unternehmen unterhält langjährige Forschungsallianzen mit den größten Pharma-Unternehmen wie Bayer, Boehringer Ingelheim, Bristol Myers Squibb, CHDI, Novartis, Novo Nordisk, Pfizer, Sanofi oder Takeda sowie mit der Havard University zur Erforschung neuer Wirkstoffe.
KeyData
endOfFinancialYear: | 31.12.2022 00:00 |
stockholderStructure: | T. Rowe Price Group (10%),Novo Holdings A/S (10%),Mubadala Investment Company (7%) |
sharesOutstanding: | 177347294.0000 |
ceo: | Dr Christian Wojczewski |
board: | Laetitia Rouxel, Dr. Cord Dohrmann, Dr. Craig Johnstone, Dr. Matthias Evers, Aurélie Dalbiez |
supervisoryBoard: | Prof. Dr. Iris Löw-Friedrich, Dr. Constanze Ulmer-Eilfort, Roland Sackers, Camilla Macapili Languille, Dr. Duncan McHale, Wes Wheeler |
countryID: | 2 |
freeFloat: | 62.1900 |
faceValueCurrencyID: | 1 |
faceValueCurrency: | EUR |
sectorName: | Biotechnologie |
industryName: | Biotechnologie |
subsectorName: | Biotechnologie |
country: | Deutschland |
countryName: | Deutschland |
Kontakt
name: | Volker Braun |
phone: | +49-40-56081-775 |
fax: | +49-40-56081-222 |
email: | InvestorRelations@evotec.com |
irWebSite: | https://www.evotec.com/en/investor-relations |
Adresse
street: | Essener Bogen 7 |
city: | D-22419 Hamburg |
phone: | +49-40-56081-0 |
fax: | +49-40-56081-222 |
webSite: | www.evotec.com |
email: | info@evotec.com |
Finanzen (kurz)
year: | 2021 | cash: | 699.3000 |
balanceSheetTotal: | 2235.2000 | liabilities: | 857.5000 |
totalShareholdersEquity: | 1377.7000 | sales: | 618.0000 |
bankLoans: | 41.0000 | investment: | 2.3000 |
incomeBeforeTaxes: | 237.0000 | netIncome: | 215.5000 |
cashFlow: | 276.8000 | employees: | 3945 |
currencyID: | 1 | units: | 1000000 |
currency: | EUR |
year: | 2022 | cash: | 415.1600 |
balanceSheetTotal: | 2257.2500 | liabilities: | 1070.0600 |
totalShareholdersEquity: | 1187.1800 | sales: | 751.4500 |
investment: | 8.3400 | incomeBeforeTaxes: | -153.9600 |
netIncome: | -175.6600 | employees: | 4952 |
currencyID: | 1 | units: | 1000000 |
currency: | EUR |
year: | 2023 | cash: | 510.9090 |
balanceSheetTotal: | 2252.4680 | liabilities: | 1132.5600 |
totalShareholdersEquity: | 1119.9080 | sales: | 781.4260 |
investment: | 9.2630 | incomeBeforeTaxes: | -80.5930 |
netIncome: | -83.9130 | employees: | 5061 |
currencyID: | 1 | units: | 1000000 |
currency: | EUR |
Finanzen (kurz)
year: | 2021 |
cash: | 699.3000 |
balanceSheetTotal: | 2235.2000 |
liabilities: | 857.5000 |
totalShareholdersEquity: | 1377.7000 |
sales: | 618.0000 |
bankLoans: | 41.0000 |
investment: | 2.3000 |
incomeBeforeTaxes: | 237.0000 |
netIncome: | 215.5000 |
cashFlow: | 276.8000 |
employees: | 3945 |
currencyID: | 1 |
units: | 1000000 |
currency: | EUR |
year: | 2022 |
cash: | 415.1600 |
balanceSheetTotal: | 2257.2500 |
liabilities: | 1070.0600 |
totalShareholdersEquity: | 1187.1800 |
sales: | 751.4500 |
investment: | 8.3400 |
incomeBeforeTaxes: | -153.9600 |
netIncome: | -175.6600 |
employees: | 4952 |
currencyID: | 1 |
units: | 1000000 |
currency: | EUR |
year: | 2023 |
cash: | 510.9090 |
balanceSheetTotal: | 2252.4680 |
liabilities: | 1132.5600 |
totalShareholdersEquity: | 1119.9080 |
sales: | 781.4260 |
investment: | 9.2630 |
incomeBeforeTaxes: | -80.5930 |
netIncome: | -83.9130 |
employees: | 5061 |
currencyID: | 1 |
units: | 1000000 |
currency: | EUR |
Finanzen (ausführlich)
year: | 2022 | units: | 1000000 |
balanceSheetTotal: | 2257.2500 | cash: | 415.1600 |
currentAssets: | 1073.6700 | fixedAssets: | 1183.5800 |
liabilities: | 337.7100 | nonCurrentLiabilities: | 732.3600 |
totalLiabilitiesEquity: | 2257.2500 | provisions: | 89.3600 |
totalShareholdersEquity: | 1187.1800 | employees: | 4952 |
property: | 650.2000 | intangibleAssets: | 23.8200 |
longTermInvestments: | 147.1000 | inventories: | 29.8300 |
accountsReceivable: | 168.6500 | accountsPayable: | 97.2800 |
liabilitiesTotal: | 1070.0600 | longTermDebt: | 490.2900 |
shortTermDebt: | 16.3800 | minorityInterests: | 0.0000 |
sales: | 751.4500 | netIncome: | -175.6600 |
operatingResult: | 20.8500 | incomeInterest: | -4.8100 |
investments: | 76.6400 | incomeTaxes: | 21.7000 |
costGoodsSold: | 577.3800 | grossProfit: | 174.1000 |
revenuePerEmployee: | 151746.7690 | cashFlow: | 203.1100 |
cashFlowInvesting: | -415.8200 | cashFlowFinancing: | -52.4100 |
accountingStandard: | IFRS | equityRatio: | 52.5941 |
debtEquityRatio: | 90.1354 | liquidityI: | 122.9339 |
liquidityII: | 172.8732 | netMargin: | -23.3761 |
grossMargin: | 23.1685 | cashFlowMargin: | 27.0291 |
ebitMargin: | 2.7746 | ebitdaMargin: | 0.0000 |
preTaxROE: | -12.9685 | preTaxROA: | -6.8207 |
roe: | -14.7964 | roa: | -7.7820 |
netIncomeGrowth: | -181.5128 | revenuesGrowth: | 21.5939 |
taxExpenseRate: | -14.0946 | equityTurnover: | 0.6330 |
epsBasic: | -0.9900 | epsBasicGrowth: | -176.1538 |
incomeBeforeTaxes: | -153.9600 | priceCashFlowRatio: | 13.2948 |
bookValuePerShare: | 6.7090 | marketCap: | 2700297484.7800 |
earningsYield: | -6.4875 | cashFlowPerShare: | 1.1478 |
netAssetsPerShare: | 6.7090 | priceBookValueRatio: | 2.2745 |
netEarningsPerShare: | -0.9927 | currency: | EUR |
year: | 2023 | units: | 1000000 |
balanceSheetTotal: | 2252.4680 | cash: | 510.9090 |
currentAssets: | 903.1620 | fixedAssets: | 1349.3060 |
liabilities: | 464.5730 | nonCurrentLiabilities: | 667.9870 |
totalLiabilitiesEquity: | 2252.4680 | provisions: | 79.3650 |
totalShareholdersEquity: | 1119.9080 | employees: | 5061 |
property: | 806.5630 | intangibleAssets: | 15.4530 |
longTermInvestments: | 142.0940 | inventories: | 30.8900 |
accountsReceivable: | 98.3960 | accountsPayable: | 134.3190 |
liabilitiesTotal: | 1132.5600 | longTermDebt: | 477.1120 |
shortTermDebt: | 149.0960 | minorityInterests: | 0.0000 |
sales: | 781.4260 | netIncome: | -83.9130 |
operatingResult: | -47.5070 | incomeInterest: | -2.4760 |
investments: | 68.5290 | incomeTaxes: | 3.3200 |
costGoodsSold: | 606.3750 | grossProfit: | 175.0510 |
minorityInterestsProfit: | 0.0000 | revenuePerEmployee: | 154401.5017 |
cashFlow: | 36.4390 | cashFlowInvesting: | -13.2910 |
cashFlowFinancing: | 71.9630 | accountingStandard: | IFRS |
equityRatio: | 49.7192 | debtEquityRatio: | 101.1297 |
liquidityI: | 109.9739 | liquidityII: | 131.1538 |
netMargin: | -10.7384 | grossMargin: | 22.4015 |
cashFlowMargin: | 4.6631 | ebitMargin: | -6.0795 |
ebitdaMargin: | 0.0000 | preTaxROE: | -7.1964 |
preTaxROA: | -3.5780 | roe: | -7.4928 |
roa: | -3.7254 | netIncomeGrowth: | -52.2299 |
revenuesGrowth: | 3.9891 | taxExpenseRate: | -4.1195 |
equityTurnover: | 0.6978 | epsBasic: | -0.4700 |
epsBasicGrowth: | -52.5253 | incomeBeforeTaxes: | -80.5930 |
priceCashFlowRatio: | 103.3175 | bookValuePerShare: | 6.3301 |
marketCap: | 3764786588.6400 | earningsYield: | -2.2086 |
cashFlowPerShare: | 0.2060 | netAssetsPerShare: | 6.3301 |
priceBookValueRatio: | 3.3617 | netEarningsPerShare: | -0.4743 |
currency: | EUR |
year: | 2024 | priceCashFlowRatio: | 43.4778 |
bookValuePerShare: | 6.3301 | marketCap: | 1584288717.1650 |
earningsYield: | -5.2485 | pegRatio: | 0.3627 |
cashFlowPerShare: | 0.2060 | netAssetsPerShare: | 6.3301 |
priceBookValueRatio: | 1.4147 | netEarningsPerShare: | -0.4743 |
currency: | EUR |
Finanzen (ausführlich)
year: | 2022 |
units: | 1000000 |
balanceSheetTotal: | 2257.2500 |
cash: | 415.1600 |
currentAssets: | 1073.6700 |
fixedAssets: | 1183.5800 |
liabilities: | 337.7100 |
nonCurrentLiabilities: | 732.3600 |
totalLiabilitiesEquity: | 2257.2500 |
provisions: | 89.3600 |
totalShareholdersEquity: | 1187.1800 |
employees: | 4952 |
property: | 650.2000 |
intangibleAssets: | 23.8200 |
longTermInvestments: | 147.1000 |
inventories: | 29.8300 |
accountsReceivable: | 168.6500 |
accountsPayable: | 97.2800 |
liabilitiesTotal: | 1070.0600 |
longTermDebt: | 490.2900 |
shortTermDebt: | 16.3800 |
minorityInterests: | 0.0000 |
sales: | 751.4500 |
netIncome: | -175.6600 |
operatingResult: | 20.8500 |
incomeInterest: | -4.8100 |
investments: | 76.6400 |
incomeTaxes: | 21.7000 |
costGoodsSold: | 577.3800 |
grossProfit: | 174.1000 |
revenuePerEmployee: | 151746.7690 |
cashFlow: | 203.1100 |
cashFlowInvesting: | -415.8200 |
cashFlowFinancing: | -52.4100 |
accountingStandard: | IFRS |
equityRatio: | 52.5941 |
debtEquityRatio: | 90.1354 |
liquidityI: | 122.9339 |
liquidityII: | 172.8732 |
netMargin: | -23.3761 |
grossMargin: | 23.1685 |
cashFlowMargin: | 27.0291 |
ebitMargin: | 2.7746 |
ebitdaMargin: | 0.0000 |
preTaxROE: | -12.9685 |
preTaxROA: | -6.8207 |
roe: | -14.7964 |
roa: | -7.7820 |
netIncomeGrowth: | -181.5128 |
revenuesGrowth: | 21.5939 |
taxExpenseRate: | -14.0946 |
equityTurnover: | 0.6330 |
epsBasic: | -0.9900 |
epsBasicGrowth: | -176.1538 |
incomeBeforeTaxes: | -153.9600 |
priceCashFlowRatio: | 13.2948 |
bookValuePerShare: | 6.7090 |
marketCap: | 2700297484.7800 |
earningsYield: | -6.4875 |
cashFlowPerShare: | 1.1478 |
netAssetsPerShare: | 6.7090 |
priceBookValueRatio: | 2.2745 |
netEarningsPerShare: | -0.9927 |
currency: | EUR |
year: | 2023 |
units: | 1000000 |
balanceSheetTotal: | 2252.4680 |
cash: | 510.9090 |
currentAssets: | 903.1620 |
fixedAssets: | 1349.3060 |
liabilities: | 464.5730 |
nonCurrentLiabilities: | 667.9870 |
totalLiabilitiesEquity: | 2252.4680 |
provisions: | 79.3650 |
totalShareholdersEquity: | 1119.9080 |
employees: | 5061 |
property: | 806.5630 |
intangibleAssets: | 15.4530 |
longTermInvestments: | 142.0940 |
inventories: | 30.8900 |
accountsReceivable: | 98.3960 |
accountsPayable: | 134.3190 |
liabilitiesTotal: | 1132.5600 |
longTermDebt: | 477.1120 |
shortTermDebt: | 149.0960 |
minorityInterests: | 0.0000 |
sales: | 781.4260 |
netIncome: | -83.9130 |
operatingResult: | -47.5070 |
incomeInterest: | -2.4760 |
investments: | 68.5290 |
incomeTaxes: | 3.3200 |
costGoodsSold: | 606.3750 |
grossProfit: | 175.0510 |
minorityInterestsProfit: | 0.0000 |
revenuePerEmployee: | 154401.5017 |
cashFlow: | 36.4390 |
cashFlowInvesting: | -13.2910 |
cashFlowFinancing: | 71.9630 |
accountingStandard: | IFRS |
equityRatio: | 49.7192 |
debtEquityRatio: | 101.1297 |
liquidityI: | 109.9739 |
liquidityII: | 131.1538 |
netMargin: | -10.7384 |
grossMargin: | 22.4015 |
cashFlowMargin: | 4.6631 |
ebitMargin: | -6.0795 |
ebitdaMargin: | 0.0000 |
preTaxROE: | -7.1964 |
preTaxROA: | -3.5780 |
roe: | -7.4928 |
roa: | -3.7254 |
netIncomeGrowth: | -52.2299 |
revenuesGrowth: | 3.9891 |
taxExpenseRate: | -4.1195 |
equityTurnover: | 0.6978 |
epsBasic: | -0.4700 |
epsBasicGrowth: | -52.5253 |
incomeBeforeTaxes: | -80.5930 |
priceCashFlowRatio: | 103.3175 |
bookValuePerShare: | 6.3301 |
marketCap: | 3764786588.6400 |
earningsYield: | -2.2086 |
cashFlowPerShare: | 0.2060 |
netAssetsPerShare: | 6.3301 |
priceBookValueRatio: | 3.3617 |
netEarningsPerShare: | -0.4743 |
currency: | EUR |
year: | 2024 |
priceCashFlowRatio: | 43.4778 |
bookValuePerShare: | 6.3301 |
marketCap: | 1584288717.1650 |
earningsYield: | -5.2485 |
pegRatio: | 0.3627 |
cashFlowPerShare: | 0.2060 |
netAssetsPerShare: | 6.3301 |
priceBookValueRatio: | 1.4147 |
netEarningsPerShare: | -0.4743 |
currency: | EUR |